Monthly report from the EU Pharmacovigilance Risk Assessment Committee (PRAC) - July 2014

15 July 2014

The EU Pharmacovigilance Risk Assessment Committee (PRAC) convened on 7-10 July 2014. Topics discussed at the meeting:

  • PRAC issues recommendation for oral methadone products containing povidone.
  • PRAC concludes review of Rienso.
  • PRAC recommends restricted use for bromocriptine in inhibiting post-partum lactation.
  • Update on the ongoing review of valproate and related substances.

Read PRAC's monthly report from the meeting 7-10 July 2014

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.